FDA Approves Lebrikizumab for Atopic Dermatitis
The US Food and Drug Administration (FDA) has approved the targeted interleukin (IL)-13 inhibitor lebrikizumab (Ebglyss) for the treatment of
All posts by Marquis Buresh
Read More »
Marquis Buresh
12:42
Nightwatchman Kerrigan hits new heights
Lancashire loanee Simon Kerrigan struck a career-best 62 and Rob Newton pronounced himself king of the half-centuries as Northants achieved
Marquis Buresh
17:19
Mexican Peso weakens on political despite positive tariff news
The Mexican Peso (MXN) trades lower on Tuesday extending the downtrend of the last few days as political risk weighs. Investors
